UREA HYDRATING TOPICAL- urea aerosol, foam

UREA HYDRATING TOPICAL by

Drug Labeling and Warnings

UREA HYDRATING TOPICAL by is a Prescription medication manufactured, distributed, or labeled by Acella Pharmaceuticals, Acella Pharmaceuticlas. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DESCRIPTION

DESCRIPTION
Urea 35% Hydrating Topical Foam is a keratolytic emollient in a water and lipid based foam containing lactic acid which is a gentle, but potent, tissue softener for skin and nails.
Each gram of Urea 35% Hydrating Topical Foam contains Urea 35% as the active ingredient, and the following inactive ingredients: dimethicone, ethylparaben, glycerin, lactic acid,
methylparaben, phenoxyethanol, polysorbate 20, povidone, propylene glycol, propylparaben, purified water, stearic acid, trolamine, and in propellants butane and propane.

CHEMICAL STRUCTURE
Urea has the following chemical structure:

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY
Topically applied urea dissolves the intercellular matrix of the skin which results in enhanced shedding of scaly, dry skin and thus a softening of the hyperkeratotic areas of the skin.
Urea topically applied to the nail plate has a similar effect on the intercellular matrix of the nail plate.

PHARMACOKINETICS

PHARMACOKINETICS
The mechanism of action of topically applied urea is not yet known.

INDICATIONS & USAGE

INDICATIONS AND USAGE
For enzymatic debridement and promotion of normal healing of surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris,
or eschar. Topically applied urea is useful for the treatment of hyperkeratotic conditions such as dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, and dry,
rough skin, as well as corns and calluses and damaged, ingrown and devitalized nails.

CONTRAINDICATIONS

CONTRAINDICATIONS
Known hypersensitivity to any of the listed ingredients.

WARNINGS

WARNINGS
Urea 35% Hydrating Topical Foam is for external use only. It is not for ophthalmic, oral, anal or intravaginal use. Contact with eyes, lips, and all mucous membranes should be
avoided. Urea 35% Hydrating Topical Foam should not be used by persons who have a known hypersensitivity to urea or any of the other listed ingredients.

PRECAUTIONS

PRECAUTIONS
Urea 35% Hydrating Topical Foam should be used only as directed by a physician and should not be used to treat any condition other than that for which it is prescribed. If redness
or irritation occurs, discontinue use and consult with a prescribing physician.

PREGNANCY

Pregnancy (Category B) – Animal reproduction studies have not been performed with topically applied urea and it is not known whether Urea 35% Hydrating Topical Foam can
cause fetal harm when administered to a pregnant woman. Nevertheless, Urea 35% Hydrating Topical Foam should be used by a pregnant woman only if necessary.

NURSING MOTHERS

Nursing Mothers – It is not known whether topically applied urea is excreted in human milk. Due to the fact that many drugs are excreted in human milk, caution should be
exercised by physicians when administering Urea 35% Hydrating Topical Foam to nursing mothers.

ADVERSE REACTIONS

ADVERSE REACTIONS
Transient stinging, burning, itching or irritation is possible.

DOSAGE & ADMINISTRATION

DOSAGE AND ADMINISTRATION
Unless otherwise directed by a prescribing physician, Urea 35% Hydrating Topical Foam should be applied to affected area twice a day. Urea 35% Hydrating Topical Foam should
be rubbed into the skin until it is completely absorbed.

HOW SUPPLIED

HOW SUPPLIED
Urea 35% Hydrating Topical Foam is supplied in a 150 gram or 5.3 ounce aerosolized canister bearing the NDC Number 42192-115-15.

SPL UNCLASSIFIED SECTION

Enter section text here

PRINCIPAL DISPLAY PANEL

PRINCIPAL DISPLAY PANEL

NDC: 42192-115-15

Urea 35% Hydrating

Topical Foam

Rx Only

Net Wt. 5.3 oz. (150 g)

NDC: 42192-115-15

Rx Only

Net Wt. 5.3 oz. (150 g)

Dosage and Administration: Clean and dry affected

skin. Then apply Urea 35% Hydrating Topical Foam

topically to cover affected skin twice per day, or as

directed by a physician. Rub in until completely absorbed.

Shake vigorously before each application and invert

can to administer.

Store at room temperature 59° - 77°F (15° - 25°C).

See prescribing information for additional details.

Ingredients: urea 35%, dimethicone, ethylparaben,

glycerin, lactic acid, methylparaben, phenoxyethanol,

polysorbate 20, povidone, propylene glycol, propylparaben,

purified water, stearic acid, trolamine, and in

propellants butane and propane.

Warning: Contents under pressure. Do not puncture or

incinerate. Do not expose to temperatures over 120°F

(48°C) even when empty.

Keep out of reach of children.

Manufactured for:

Acella Pharmaceuticals, LLC

Alpharetta, GA 30009

1-800-541-4802

INGREDIENTS AND APPEARANCE

UREA HYDRATING TOPICAL 
urea aerosol, foam

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 42192-115
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
UREA (UNII: 8W8T17847W) (UREA - UNII:8W8T17847W)	UREA	35 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
DIMETHICONE (UNII: 92RU3N3Y1O)
ETHYLPARABEN (UNII: 14255EXE39)
GLYCERIN (UNII: PDC6A3C0OX)
LACTIC ACID (UNII: 33X04XA5AT)
METHYLPARABEN (UNII: A2I8C7HI9T)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
POLYSORBATE 20 (UNII: 7T1F30V5YH)
POVIDONE (UNII: FZ989GH94E)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
PROPYLPARABEN (UNII: Z8IX2SC1OH)
WATER (UNII: 059QF0KO0R)
STEARIC ACID (UNII: 4ELV7Z65AP)
TROLAMINE (UNII: 9O3K93S3TK)
BUTANE (UNII: 6LV4FOR43R)
PROPANE (UNII: T75W9911L6)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 42192-115-15	150 g in 1 CANISTER; Type 0: Not a Combination Product	05/21/2010

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		05/21/2010

Labeler - Acella Pharmaceuticals (825380939)

Registrant - Acella Pharmaceuticals (825380939)

Establishment
Name	Address	ID/FEI	Business Operations
Acella Pharmaceuticlas		825380939	manufacture(42192-115)